AlphaCentric Advisors »

Avadel Pharmaceuticals shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of Avadel Pharmaceuticals (AVDL) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in Avadel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Avadel Pharmaceuticals held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avadel Pharmaceuticals by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $354k 34k 10.51

More positions owned by AlphaCentric Advisors

Eli Lilly & Co. (LLY)
UnitedHealth (UNH)
Johnson & Johnson (JNJ)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Abbvie (ABBV)
Merck & Co (MRK)
Thermo Fisher Scientific (TMO)
Astrazeneca Sponsored Adr (AZN)
Novo-nordisk A S Adr (NVO)
Globus Med Cl A (GMED)
Invesco Exchange Traded Fd T S&p500 Pur Val (RPV)
Ishares Tr Rus 1000 Val Etf (IWD)
Intuitive Surgical Com New (ISRG)
Lamar Advertising Cl A (LAMR)
Boston Scientific Corporation (BSX)

View all positions for AlphaCentric Advisors

Top funds holding Avadel Pharmaceuticals

Henderson Group
BlackRock
Vanguard Group
Brandes Investment Partners
Two Seas Capital
Jeffrey L. Gendell
Polar Capital Holdings
Vivo Capital
State Street Corporation
Wealth Effects
Geode Capital Management
Tang Capital Management
Susquehanna International
Kennedy Capital Management
Citadel Advisors

View all funds holding Avadel Pharmaceuticals